Alibasa, Bhairose M.

HRN: 19-84-36  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2026
CEFTRIAXONE 1G (VIAL)
08/09/2026
08/15/2026
IV DRIP
1.4g
OD
Dengue Shock Syndrome; T/C Acute Bacterial Infection
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: